References
- 1. Kamili MA, G A, Dar IH, Dar SH, Wazir HS, Qureishi T. Orbital pseudotumor. Oman J Ophthalmol. 2009;2(2):96-99.10.4103/0974-620X.53043
- 2. Grouteau E, Chaix Y, Armbruster V, Lesueur L, Sevely A, Rubie H, Carriere JP. Acute orbital myositis and idiopathic inflammatory pseudotumor in children: three cases. Arch Pediatr. 1998;5:153-158.10.1016/S0929-693X(97)86829-7
- 3. Yeşiltaş YS, Gündüz AK. Idiopathic Orbital Inflammation: Review of Literature and New Advances. Middle East Afr J Ophthalmol. 2018;25(2):71-80.10.4103/meajo.MEAJO_44_18607134730122852
- 4. Ferreira TA, Saraiva P, Genders SW, Buchem MV, Luyten GPM, Beenakker JW. CT and MR imaging of orbital inflammation. Neuroradiology. 2018;60(12):1253-1266.10.1007/s00234-018-2103-4624499730310941
- 5. Narla LD, Newman B, Spottswood SS, Narla S, Kolli R. Inflammatory Pseudotumor. Radiographics. 2003;23:7190-720.10.1148/rg.23302507312740472
- 6. Bahn RS. Graves’ ophthalmopathy. N Engl J Med. 2010;362(8):726-738.10.1056/NEJMra0905750390201020181974
- 7. Caminha LSC, Pinto ER, Medeiros de Sousa PA, Oliveira RA, Conceiçao FL, Vaisman M. Orbital pseudotumor: a differential diagnosis of Graves’ ophthalmopathy. Arq Bras Endocrinol Metab. 2011;55(1):85-88.10.1590/S0004-2730201100010001321468526
- 8. Stan MN, Garrity JA, Bahn RS. The evaluation and treatment of graves ophthalmopathy. Med Clin North Am. 2012;96(2):311-328.10.1016/j.mcna.2012.01.014389879022443978
- 9. Chaudhry IA, Shamsi FA, Arat YO, Riley FC. Orbital pseudotumor: distinct diagnostic features and management. Middle East Afr J Ophthalmol. 2008;15(1):17-27.10.4103/0974-9233.53370284879520379424
- 10. Gleason JE. Idiopathic Myositis involving the extraocular muscles. Opthalmol Rec. 1903;12:471-8.
- 11. Birch-Hirschfeld A. Zur diagnostic and pathologic der orbital tumoren. Ber Dtsch Opthalmol Ges. 1905;32:127-35.
- 12. Bodu N, Jumani M, Wadhwa V, Bajaj G, Faas F. Not All Orbitopathy Is Graves’: Discussion of Cases and Review of Literature. Front. Endocrinol. 2017;8(184):1-6.
- 13. Bahn RS, Heufelder AE. Pathogenesis of Graves’ ophthalmopathy. N Engl J Med (1993) 329(20):1468–75.10.1056/NEJM1993111132920078413459
- 14. Lacey B, Chang W, Rootman J. Nonthyroid causes of extraocular muscle disease. Surv Ophthalmol. 1999;44(3):187-213.10.1016/S0039-6257(99)00101-0
- 15. Khoo DH, Eng PH, Ho SC, et al. Graves’ ophthalmopathy in the absence of elevated free thyroxine and triiodothyronine levels: prevalence, natural history, and thyrotropin receptor antibody levels. Thyroid. 2000;10:1093–1100.10.1089/thy.2000.10.109311201855
- 16. Stanciu M, Popa FL, Totoian IG, Bera LG. Orbital pseudotumor can mimic Graves’ ophthalmopathy. Acta Endocrinol (Buchar). 2016;12(3):344-348.10.4183/aeb.2016.344653525731149112
- 17. San Miguel I, Arenas M, Carmona R, Rutllan J, Medina-Rivero F, Lara P. Review of the treatment of Graves’ ophthalmopathy: The role of the new radiation techniques. Saudi J Ophthalmol. 2018;32(2):139-145.10.1016/j.sjopt.2017.09.003601059029942184
- 18. Günalp I, Gündüz K, Yazar Z. Idiopathic orbital inflammatory disease. Acta Ophthalmol Scand. 1996 Apr;74(2):191-3.10.1111/j.1600-0420.1996.tb00069.x8739689
- 19. Yuen SJ, Rubin PA. Idiopathic orbital inflammation: distribution, clinical features, and treatment outcome. Arch Ophthalmol. 2003 Apr;121(4):491-9.10.1001/archopht.121.4.49112695246